Novartis India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Novartis India Ltd. on BSE

Search Inside the pdf :

Novartis India Ltd.

04 Mar 2025

780.00

1.69%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Integrated Filing (Financial)

BSE India

Integrated filing (Financial) for the Quarter and nine months ended December 31 2024.

pdf

Novartis India Ltd.

20 Feb 2025

780.00

1.69%

Company Update

NOVARTIS INDIA LTD. - 500672 - This Is To Inform That The Company Has Received Order …

BSE India

This is to inform that the Company has received order from Assistant Commissioner of CGST and Central Excise and disclosure is given pursuant to Regulation 30 read with Clause 20 Para A of Schedule III

pdf

Novartis India Ltd.

29 Jan 2025

780.00

1.69%

Company Update

NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

This intimation is in relation to the publication of financial results for the Quarter ended as on December 31, 2024, approved by the Board in their meeting held on January 28, 2025, in Newspapers "Financial Express and Navshakti on January 29, 2025.

pdf

Novartis India Ltd.

28 Jan 2025

780.00

1.69%

Result

NOVARTIS INDIA LTD. - 500672 - Filing Of Unaudited Financial Results And Limited Review Report For …

BSE India

We hereby inform that the Board of Directors of the Company at its meeting held today January 28, 2025 have approved the unaudited financials results of the company for the quarter and nine months ended December 31, 2024 as recommended by the Audit Committee

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	103.60	97.42	106.50	6.3%	-2.7%
Operating Profit Qtr	25.58	17.96	19.77	42.4%	29.4%
Net Profit Qtr	25.45	20.41	26.57	24.7%	-4.2%
Earning Per Share Adjusted latest Qtr	10.31	8.27	10.76	24.7%	-4.2%

* Standalone data

Detailed Results

Novartis India Ltd.

28 Jan 2025

780.00

1.69%

Board Meeting

NOVARTIS INDIA LTD. - 500672 - Board Meeting Outcome for Filing Of Outcome Of The Meeting …

BSE India

We hereby inform that the Board of Directors ('Board') of the Company at its Meeting held today i.e. January 28, 2025 inter-alia have considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024 as recommended by the Audit Committee of the Company.

pdf

Novartis India Ltd.

10 Jan 2025

780.00

1.69%

Company Update

NOVARTIS INDIA LTD. - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

This intimation is filed to submit the compliance certificate issued by MUFG Intime India Private limited(formerly known as Link Intime India Private Limited) dated January 07, 2025 under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, for the quarter ended December 31, 2024.

pdf

Novartis India Ltd.

27 Dec 2024

780.00

1.69%

Board Meeting

NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Approval Of Quarterly Financial Results For …

BSE India

NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve The intimation is filed to inform that the Board Meeting of the Company shall be held on Tuesday, January 28, 2025, for approval of Quarterly Financial Results for the Quarter ended as on December 31, 2024.

pdf

Novartis India Ltd.

27 Dec 2024

780.00

1.69%

SAST

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

BSE India

The Board Meeting of the Company for the approval of unaudited financial results for the quarter ended as on Dec 31, 2024 shall be convened on Tuesday, January 28, 2025. The Trading window is closed for the designated persons/insiders, connected persons and their immediate relatives from Wednesday, January 01, 2025 and shall open after 48 hours from the declaration of quarterly financial results ended as on Dec 31, 2024, to Stock exchange by the Company (i.e. till Thursday, January 30, 2025)

More...

pdf

Novartis India Ltd.

27 Dec 2024

780.00

1.69%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation under regulation 39(3) of SEBI LODR Regulation, received from the RTA of the company on December 25, 2024 for loss of share certificate by the shareholder of the company.

pdf

Novartis India Ltd.

05 Dec 2024

780.00

1.69%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of intimation as received from RTA for the loss of share certificate by the shareholder dated December 05, 2024 under Reg 39(3) of SEBI LODR 2015

pdf

No results found

Is Novartis India Ltd. worth buying?

61 Votes:

Buy 72.13%

Sell 16.39%

Hold 11.48%